Table:
begin	end	state
1	17	cytoplasmic
18	36	transmembrane
37	56	non-cytoplasmic
57	77	transmembrane
78	94	cytoplasmic
95	115	transmembrane
116	149	non-cytoplasmic
150	172	transmembrane
173	192	cytoplasmic
193	220	transmembrane
221	238	non-cytoplasmic
239	260	transmembrane
261	271	cytoplasmic
272	298	transmembrane
299	324	non-cytoplasmic
325	348	transmembrane
349	358	cytoplasmic
359	385	transmembrane
386	404	non-cytoplasmic
405	433	transmembrane
434	452	cytoplasmic
453	472	transmembrane
473	482	non-cytoplasmic
483	504	transmembrane
505	519	cytoplasmic

Input:
>3607157 FitnessBrowser__Dino:3607157
MSDTTRTPGLAPKGADKALFAVTGGFIALFCAYALFDIEGLSALVDTSFAFSAKYFGLYW
QVLLLATFLIGLVLCFLPGSRTLMGGLSTPEFGTFSWAAMIMCTLLAGGGVFWAAGEPIA
HFLSTPPVFGDLSGDVQAQAHAALAQSFLHWGFLAWAILGSLTTVMLMHYHYDKGLPLAP
RTLLYPLLGDRALSGPIGLIADASCIIAVVAGTVGPIGFLGLQMSYGLNDLTGIPDTFAT
QAIAILALVGLYTVSAITGLAKGIKILSQINVLLAVVLLIFMLVAGPTMNIFAGFFGGMQ
VYATHFFDMAMYRGDAGLFGDAGWLGWWTVFFWGWFMGYGPLMAVFIARISRGRSIRQII
ITLSIAAPLITNFWFTIIGGSGIFFEIAEPGVVSGPFEGFNLPAGLLAITQAMPMGLILS
VLFLVLTMCFVATTSDSMSYVISSTMTDGEPSTAMRAFWGLAMGVMALILISTGEGGIGK
LQSFIVVTAVPVSLILLPSLWDALRITWMLGRTPEAKHA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server